{"protocolSection":{"identificationModule":{"nctId":"NCT04441437","orgStudyIdInfo":{"id":"104-9569A3"},"organization":{"fullName":"Chang Gung Memorial Hospital","class":"OTHER"},"briefTitle":"The Efficacy of Dynamic Hand Splint Treatment in Spastic Hemiparetic Patients","officialTitle":"The Efficacy of Dynamic Hand Splint Treatment in Spastic Hemiparetic Patients: A Randomized Controlled Trial"},"statusModule":{"statusVerifiedDate":"2020-06","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2016-11-04","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2019-03-22","type":"ACTUAL"},"completionDateStruct":{"date":"2019-03-22","type":"ACTUAL"},"studyFirstSubmitDate":"2020-06-16","studyFirstSubmitQcDate":"2020-06-18","studyFirstPostDateStruct":{"date":"2020-06-22","type":"ACTUAL"},"lastUpdateSubmitDate":"2020-06-19","lastUpdatePostDateStruct":{"date":"2020-06-23","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Chu-Hsu Lin","investigatorTitle":"Principal Investigator","investigatorAffiliation":"Chang Gung Memorial Hospital"},"leadSponsor":{"name":"Chang Gung Memorial Hospital","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The purpose of this randomized controlled trial was designed to study the efficacy of dynamic hand splinting on spastic hemiparetic patients due to stroke or traumatic brain injury.","detailedDescription":"Subjects were recruited from both inpatients and outpatients who received rehabilitation programs in the Department of Physical Medicine and Rehabilitation at a regional teaching hospital in Taiwan. The participants were randomly divided into two groups: the splint group and the control group. The subjects in the splint group received 1-hour task-oriented training with wearing a customized dynamic hand splint, totally 15 times in a duration of one month plus conventional rehabilitation programs. The subjects in the control group received the same treatments but without splint used. Evaluations including Modified Ashworth Scale (MAS), active range of motion (AROM), grip strength, Fugl-Meyer Assessment (FMA), Motor Activity Log 30(MAL), and F/M ratio were performed at baseline, post-training, and 2 months later after the intervention finished, and the evaluators were blinded to the grouping of the subjects."},"conditionsModule":{"conditions":["Stroke","Brain Injuries"],"keywords":["spasticity","dynamic hand splint","stroke","traumatic brain injury"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"SINGLE","whoMasked":["OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":35,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Splint Group","type":"EXPERIMENTAL","description":"1-hour task-oriented training with wearing a customized dynamic hand splint, totally 15 times in a duration of one month.","interventionNames":["Behavioral: Task-oriented training with a dynamic hand splint"]},{"label":"No-Splint Group","type":"PLACEBO_COMPARATOR","description":"1-hour task-oriented training without wearing a customized dynamic hand splint, totally 15 times in a duration of one month.","interventionNames":["Behavioral: Task-oriented training without a dynamic hand splint"]}],"interventions":[{"type":"BEHAVIORAL","name":"Task-oriented training with a dynamic hand splint","description":"In addition to conventional rehabilitation programs (therapy-as-usual), the subject in the splint group received 1-hour task-oriented training with wearing a customized dynamic hand splint, totally 15 times in a duration of one month. The content of task-oriented training contained picking cubes from side to side with three-jaw grasp, lifting the cone to the shoulder height with the cylindrical grip and an extended elbow, picking up pegs and inserting it into the hole with palmar pinch, and grasping a soap to simulate wiping the body. Among the four tasks, two were chosen to train the subjects according to the abilities of subjects.","armGroupLabels":["Splint Group"]},{"type":"BEHAVIORAL","name":"Task-oriented training without a dynamic hand splint","description":"In addition to conventional rehabilitation programs (therapy-as-usual), the subject in the no-splint group received 1-hour task-oriented training, totally 15 times in a duration of one month. The content of task-oriented training contained picking cubes from side to side with three-jaw grasp, lifting the cone to the shoulder height with the cylindrical grip and an extended elbow, picking up pegs and inserting it into the hole with palmar pinch, and grasping a soap to simulate wiping the body. Among the four tasks, two were chosen to train the subjects according to the abilities of subjects.","armGroupLabels":["No-Splint Group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Modified Ashworth Scale (MAS)","description":"A participant was made in sitting position with the palm of the affected side placed at the edge of table. Then his or her 2nd to 5th fingers was moved by the examiner from maximum possible flexion to maximum possible extension over a duration of about one second. All of the four fingers were done at once. The participant's wrist and elbow were then also tested in the same manner. The lowest score was zero and the highest score was 415. For statistical purposes, the MAS score '1+' is considered as 2, '2' as 3, and so on until 5.","timeFrame":"Performed at baseline"},{"measure":"Post-training Change of Modified Ashworth Scale (MAS)","description":"A participant was made in sitting position with the palm of the affected side placed at the edge of table. Then his or her 2nd to 5th fingers was moved by the examiner from maximum possible flexion to maximum possible extension over a duration of about one second. All of the four fingers were done at once. The participant's wrist and elbow were then also tested in the same manner. The lowest score was zero and the highest score was 415. For statistical purposes, the MAS score '1+' is considered as 2, '2' as 3, and so on until 5.","timeFrame":"Change from baseline at average 30 days"},{"measure":"3-Month Follow-up Change of Modified Ashworth Scale (MAS)","description":"A participant was made in sitting position with the palm of the affected side placed at the edge of table. Then his or her 2nd to 5th fingers was moved by the examiner from maximum possible flexion to maximum possible extension over a duration of about one second. All of the four fingers were done at once. The participant's wrist and elbow were then also tested in the same manner. The lowest score was zero and the highest score was 415. For statistical purposes, the MAS score '1+' is considered as 2, '2' as 3, and so on until 5.","timeFrame":"Change from baseline at average 90 days"},{"measure":"Active range of motion (AROM)","description":"A participant in sitting position with the palm of the affected side placed at the edge of table was instructed to actively move his or her fingers and wrists as much as possible. Then the AROM of the index finger and wrist were measured by a goniometer.","timeFrame":"Performed at baseline"},{"measure":"Post-training Change of Active range of motion (AROM)","description":"A participant in sitting position with the palm of the affected side placed at the edge of table was instructed to actively move his or her fingers and wrists as much as possible. Then the AROM of the index finger and wrist were measured by a goniometer.","timeFrame":"Change from baseline at average 30 days"},{"measure":"3-Month Follow-up Change of Active range of motion (AROM)","description":"A participant in sitting position with the palm of the affected side placed at the edge of table was instructed to actively move his or her fingers and wrists as much as possible. Then the AROM of the index finger and wrist were measured by a goniometer.","timeFrame":"Change from baseline at average 90 days"},{"measure":"Grip strength","description":"For the grip strength measurement, a participant in sitting position was instructed to squeeze a dynamometer with the unaffected hand as hard as he or she can for about 3 seconds. Then the hand of affected side was tested in the same manner. Three consecutive measurements with a 3-minute interval were performed for each hand and the arithmetic mean value of the 3 trials was used for statistical analysis.","timeFrame":"Performed at baseline"},{"measure":"Post-training Change of Grip strength","description":"For the grip strength measurement, a participant in sitting position was instructed to squeeze a dynamometer with the unaffected hand as hard as he or she can for about 3 seconds. Then the hand of affected side was tested in the same manner. Three consecutive measurements with a 3-minute interval were performed for each hand and the arithmetic mean value of the 3 trials was used for statistical analysis.","timeFrame":"Change from baseline at average 30 days"},{"measure":"3-Month Follow-up Change of Grip strength","description":"For the grip strength measurement, a participant in sitting position was instructed to squeeze a dynamometer with the unaffected hand as hard as he or she can for about 3 seconds. Then the hand of affected side was tested in the same manner. Three consecutive measurements with a 3-minute interval were performed for each hand and the arithmetic mean value of the 3 trials was used for statistical analysis.","timeFrame":"Change from baseline at average 90 days"},{"measure":"Motor Activity Log 30(MAL)","description":"Using the standardized questions from the upper-extremity MAL, a participant was rated how much (Amount of Use scale, MAL-AOU) and how well (Quality of Movement scale, MAL-QOM) he or she used the upper limb of affected side to accomplish each functional activity during the past week. Both scales were anchored at 6 points (AOU scale: 0 = not used, 5 = the same as before stroke or brain injury; QOM scale: 0 = not used, 5 = normal).17, 18 A mean MAL score is the mean of all item scores.","timeFrame":"Performed at baseline"},{"measure":"Post-training Change of Motor Activity Log 30(MAL)","description":"Using the standardized questions from the upper-extremity MAL, a participant was rated how much (Amount of Use scale, MAL-AOU) and how well (Quality of Movement scale, MAL-QOM) he or she used the upper limb of affected side to accomplish each functional activity during the past week. Both scales were anchored at 6 points (AOU scale: 0 = not used, 5 = the same as before stroke or brain injury; QOM scale: 0 = not used, 5 = normal).17, 18 A mean MAL score is the mean of all item scores.","timeFrame":"Change from baseline at average 30 days"},{"measure":"3-Month Follow-up Change of Motor Activity Log 30(MAL)","description":"Using the standardized questions from the upper-extremity MAL, a participant was rated how much (Amount of Use scale, MAL-AOU) and how well (Quality of Movement scale, MAL-QOM) he or she used the upper limb of affected side to accomplish each functional activity during the past week. Both scales were anchored at 6 points (AOU scale: 0 = not used, 5 = the same as before stroke or brain injury; QOM scale: 0 = not used, 5 = normal).17, 18 A mean MAL score is the mean of all item scores.","timeFrame":"Change from baseline at average 90 days"},{"measure":"Fugl-Meyer Assessment (FMA)","description":"For the Fugl-Meyer Upper Extremity Assessment (FMA), a 3-graded scale with 0 as minimum and 2 as maximum was applied for grading of sensorimotor function.19 The testing procedure was conducted in a standardized manner according to the written instructions originally published and some additional general guidelines.20, 21 For motor function assessment, the Fugl-Meyer Assessment for upper extremity (FMA-UE) was used. Clear and precise instructions were given to a seated participant for each movement. The unaffected side simulated first and then the affected side was evaluated. Each activity was repeated 3 times and the highest score was recorded. The maximum total score was 66. For sensory function assessment, the Modified Fugl-Meyer sensory assessment (FMA-sensory) was used. This included tests of the light touch, temperature, tactile localization and position sensation of the upper arm, forearm, hand, thigh, calf and foot of the affected side. The maximum total score was 44.","timeFrame":"Performed at baseline"},{"measure":"Post-training Change of Fugl-Meyer Assessment (FMA)","description":"For the Fugl-Meyer Upper Extremity Assessment (FMA), a 3-graded scale with 0 as minimum and 2 as maximum was applied for grading of sensorimotor function.19 The testing procedure was conducted in a standardized manner according to the written instructions originally published and some additional general guidelines.20, 21 For motor function assessment, the Fugl-Meyer Assessment for upper extremity (FMA-UE) was used. Clear and precise instructions were given to a seated participant for each movement. The unaffected side simulated first and then the affected side was evaluated. Each activity was repeated 3 times and the highest score was recorded. The maximum total score was 66. For sensory function assessment, the Modified Fugl-Meyer sensory assessment (FMA-sensory) was used. This included tests of the light touch, temperature, tactile localization and position sensation of the upper arm, forearm, hand, thigh, calf and foot of the affected side. The maximum total score was 44.","timeFrame":"Change from baseline at average 30 days"},{"measure":"3-Month Follow-up Change of Fugl-Meyer Assessment (FMA)","description":"For the Fugl-Meyer Upper Extremity Assessment (FMA), a 3-graded scale with 0 as minimum and 2 as maximum was applied for grading of sensorimotor function.19 The testing procedure was conducted in a standardized manner according to the written instructions originally published and some additional general guidelines.20, 21 For motor function assessment, the Fugl-Meyer Assessment for upper extremity (FMA-UE) was used. Clear and precise instructions were given to a seated participant for each movement. The unaffected side simulated first and then the affected side was evaluated. Each activity was repeated 3 times and the highest score was recorded. The maximum total score was 66. For sensory function assessment, the Modified Fugl-Meyer sensory assessment (FMA-sensory) was used. This included tests of the light touch, temperature, tactile localization and position sensation of the upper arm, forearm, hand, thigh, calf and foot of the affected side. The maximum total score was 44.","timeFrame":"Change from baseline at average 90 days"},{"measure":"F/M ratio of ulnar nerve","description":"An electrophysiological examination was performed with an active recording surface electrode (G1) placed over the belly of the abductor digiti minimi of the affected side, a reference electrode (G2) placed on the phalanx of the little finger, and a ground electrode placed on the back of the hand between the stimulating and recording electrodes. Supra-maximal stimulations at the wrist 8 cm away from G1 was performed to obtain the compound muscle action potential (CMAP) and F wave of the ADM muscle with the cathode distal and proximal to the anode, respectively. The stimulation was given less than 1 Hz to avoid influences from the previous stimulus. The ratio of amplitude of the mean and the maximal F-wave to the CMAP (F/M ratio) were then calculated.","timeFrame":"Performed at baseline"},{"measure":"Post-training Change of F/M ratio of ulnar nerve","description":"An electrophysiological examination was performed with an active recording surface electrode (G1) placed over the belly of the abductor digiti minimi of the affected side, a reference electrode (G2) placed on the phalanx of the little finger, and a ground electrode placed on the back of the hand between the stimulating and recording electrodes. Supra-maximal stimulations at the wrist 8 cm away from G1 was performed to obtain the compound muscle action potential (CMAP) and F wave of the ADM muscle with the cathode distal and proximal to the anode, respectively. The stimulation was given less than 1 Hz to avoid influences from the previous stimulus. The ratio of amplitude of the mean and the maximal F-wave to the CMAP (F/M ratio) were then calculated.","timeFrame":"Change from baseline at average 30 days"},{"measure":"3-Month Follow-up Change of F/M ratio of ulnar nerve","description":"An electrophysiological examination was performed with an active recording surface electrode (G1) placed over the belly of the abductor digiti minimi of the affected side, a reference electrode (G2) placed on the phalanx of the little finger, and a ground electrode placed on the back of the hand between the stimulating and recording electrodes. Supra-maximal stimulations at the wrist 8 cm away from G1 was performed to obtain the compound muscle action potential (CMAP) and F wave of the ADM muscle with the cathode distal and proximal to the anode, respectively. The stimulation was given less than 1 Hz to avoid influences from the previous stimulus. The ratio of amplitude of the mean and the maximal F-wave to the CMAP (F/M ratio) were then calculated.","timeFrame":"Change from baseline at average 90 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* an age of 20 to 85 years\n* the duration of stroke or brain injury more than 6 months\n* unilateral hemiparesis with intact sound side limbs function\n* the Brunnstrom's stage of both arm and hand â‰¥ III\n* able to follow instructions, wear a dynamic hand splint and perform therapeutic activities\n* wrist spasticity with a Modified Ashworth Scale score 1-3\n* willing to provide the written informed consent.\n\nExclusion Criteria:\n\n* patients with apraxia\n* cognitive impairment with a Mini-Mental State Examination (MMSE) score \\< 25\n* any fixed contracture of the affected wrist or fingers\n* a history of peripheral nerve injury, other severe neuromuscular disease or musculoskeletal deformity change in the affected side upper extremity\n* a history of alcohol or phenol injection to the affected side upper extremity\n* Botulinum toxin injection to the affected side upper extremity for the treatment of spasticity within 4 months before the study\n* surgical treatment for spasticity to the affected side upper extremity\n* active infection\n* obvious atrophy of muscles in the affected side upper extremity\n* bilateral upper extremities weakness\n* any dermatosis or open wounds in the affected upper extremity or an allergy to the splint.","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Chu-Hsu Lin, MD","affiliation":"Chang Gung Memorial Hospital","role":"PRINCIPAL_INVESTIGATOR"}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000001930","term":"Brain Injuries"}],"ancestors":[{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000006259","term":"Craniocerebral Trauma"},{"id":"D000020196","term":"Trauma, Nervous System"},{"id":"D000014947","term":"Wounds and Injuries"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M4897","name":"Brain Injuries","asFound":"Brain Injury","relevance":"HIGH"},{"id":"M628","name":"Brain Injuries, Traumatic","relevance":"LOW"},{"id":"M11775","name":"Muscle Spasticity","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17375","name":"Wounds and Injuries","relevance":"LOW"},{"id":"M9039","name":"Craniocerebral Trauma","relevance":"LOW"},{"id":"M21713","name":"Trauma, Nervous System","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC26","name":"Wounds and Injuries"},{"abbrev":"BC05","name":"Musculoskeletal Diseases"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}